BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 5, 2020
View Archived Issues
EZH2 has dual role
Read More
Imitating ticks to evade immunity
Read More
ValiRx collaborates with Oncolytika and Black Cat Bio to explore combination treatment for COVID-19
Read More
Inovio and partners to initiate phase I/II study of COVID-19 DNA vaccine in South Korea
Read More
Intravacc announces partnership to develop intranasal COVID-19 vaccine
Read More
IRLAB announces preparations for phase IIb/III study of mesdopetam in PD
Read More
PharmAust reports preliminary data for monepantel in models of SARS-CoV-2 infection
Read More
CytomX presents first-in-human data for CX-2029
Read More
Onconova Therapeutics describes multi-specific protein kinase inhibitors
Read More
Type-1 angiotensin II receptor antagonists discovered at MFC
Read More
Forge Therapeutics patents bacterial LpxC inhibitors
Read More
New JAK1 inhibitors identified at HK inno.N Corp.
Read More
Phase I data for mRNA-2752 as monotherapy or in combination with durvalumab
Read More
Nippon Shinyaku discovers pim-1 kinase inhibitors
Read More
Selective TREK channel activator alleviates pain in mice without opioid-like adverse effects
Read More
Identification of inhibitors of the main protease of SARS-CoV-2
Read More
Results presented for GC-1118 with irinotecan or FOLFIRI in patients with metastatic solid tumors
Read More
Meiji Seika Pharma discontinues development of ME-1111 for treatment of onychomycosis
Read More
Phase III STEP 1 trial of semaglutide in obesity meets primary endpoints
Read More
Molecular pair offers potential Parkinson's treatment
Read More
FDA places clinical hold on phase II/III trial of LYS-SAF-302 gene therapy for MPS IIIA
Read More
FDA approves Recarbrio for hospital-acquired and ventilator-associated bacterial pneumonia
Read More
FDA clears IND for phase I/II trial of autologous cell therapy EXG-34217
Read More
Anti-PD-1 MAb zimberelimab shows promise in patients with recurrent or metastatic cervical cancer
Read More
PDS Biotechnology announces phase II trial of PDS-0101 with chemoradiotherapy for cervical cancer
Read More
DMX-200 to be studied for COVID-19 within REMAP-CAP program
Read More
CEPI supports development of BBV-87 vaccine against Chikungunya
Read More